Weekly oral bisphosphonates over 2 years prevent bone loss in cardiac transplant patients.

Uwe LangeKatharina ClassenUlf Müller-LadnerManfred Richter

Published in: Clinical transplantation (2017)

In heart transplanted patients, weekly oral bisphosphonates in combination with calcium and vitamin D supplementation preserved bone mass, prevented uncoupling of bone resorption/formation and fractures. Bone density should be measured and adequately treated, that is, with regular bisphosphonates.

Keyphrases

bone loss
end stage renal disease
newly diagnosed
ejection fraction
bone mineral density
heart failure
peritoneal dialysis
left ventricular
soft tissue
nitric oxide